Tetra Radar · Company Timeline

Johnson & Johnson (JNJ)

Sector: Health Care

Earlier observations

  1. · FDA approval. The FDA approved ICOTYDE to treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy.
  2. · FDA approval. The FDA approved PREZCOBIX in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) in treatment-naïve and treatment-experienced adults and pediatric patients 3 years of age and….
  3. · FDA approval. The FDA approved RYBREVANT FASPRO in combination with lazertinib for the first-line treatment of adult patients with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R substitution mutations…, and other uses.

Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.

Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.